Elevated Frequencies of Circulating Th22 Cell in Addition to Th17 Cell and Th17/Th1 Cell in Patients with Acute Coronary Syndrome

Background Atherosclerosis is a chronic inflammatory disease mediated by immune cells. Th22 cells are CD4+ T cells that secret IL-22 but not IL-17 or IFN-γ and are implicated in the pathogenesis of inflammatory disease. The roles of Th22 cells in the pathophysiologic procedures of acute coronary syndrome (ACS) remain unclear. The purpose of this study is to investigate the profile of Th22, Th17 and Th17/Th1 cells in ACS patients, including unstable angina (UA) and acute myocardial infarction (AMI) patients. Design and Methods In this study, 26 AMI patients, 16 UA patients, 16 stable angina (SA) patients and 16 healthy controls were included. The frequencies of Th22, Th17 and Th17/Th1 cells in AMI, UA, SA patients and healthy controls were examined by flow cytometry. Plasma levels of IL-22, IL-17 and IFN-γ were measured by enzyme-linked immunosorbent assay (ELISA). Results Th22, Th17 and Th17/Th1 cells were significantly increased in AMI and UA patients compared with SA patients and healthy controls. Moreover, plasma IL-22 level was significantly elevated in AMI and UA patients. In addition, Th22 cells correlated positively with IL-22 as well as Th17 cells in AMI and UA patients. Conclusion Our findings showed increased frequencies of both Th22 and Th17 cells in ACS patients, which suggest that Th22 and Th17 cells may play a potential role in plaque destabilization and the development of ACS.

• Publication year

  2013

• Venue

  PLoS ONE

• Publication date

  2013-12-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pone.0071466PMID 24312440PMCID 3849482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation, Atherosclerosis and Coronary Artery Disease

  2014cited by this paper
• Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis

  2012cited by this paper
• Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome.

  2011cited by this paper
• Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease

  2011cited by this paper
• Elevated Th22 Cells Correlated with Th17 Cells in Patients with Rheumatoid Arthritis

  2011cited by this paper
• IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma

  2011cited by this paper
• IL-22 Induces an Acute-Phase Response

  2010cited by this paper
• The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome.

  2010cited by this paper
• Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy.

  2010cited by this paper
• Circulating Th17, Th22, and Th1 cells are increased in psoriasis.

  2010cited by this paper
• 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis.

  2010cited by this paper
• Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice

  2010cited by this paper
• Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall

  2010cited by this paper
• Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice1

  2009cited by this paper
• Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells

  2009cited by this paper
• Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells

  2009cited by this paper
• Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

  2009cited by this paper
• Do studies in humans better depict Th17 cells?

  2009cited by this paper
• Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus

  2009cited by this paper
• Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.

  2009cited by this paper
• Role of Pro-/Anti-Inflammatory Cytokines and Their Correlation With Established Risk Factors in South Indians With Coronary Artery Disease

  2009cited by this paper
• Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

  2009cited by this paper
• CorrigendumCorrigendum to “The Th17/Treg imbalance in patients with acute coronary syndrome” [Clin. Immunol. 127 (2008) 89–97]

  2009cited by this paper
• Interferon gamma: a master regulator of atherosclerosis.

  2009cited by this paper
• Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells

  2009cited by this paper
• The Th17/Treg imbalance in patients with acute coronary syndrome.

  2008cited by this paper
• Th17 cell differentiation: the long and winding road.

  2008cited by this paper
• Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

  2007cited by this paper
• Phenotypic and functional features of human Th17 cells

  2007cited by this paper
• Inhibition of Progression and Stabilization of Plaques by Postnatal Interferon-γ Function Blocking in ApoE-Knockout Mice

  2007cited by this paper
• IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1

  2007cited by this paper
• Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

  2007cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.

  2006cited by this paper
• Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

  2006cited by this paper
• Hydrodynamic-Based Delivery of an Interleukin-22-Ig Fusion Gene Ameliorates Experimental Autoimmune Myocarditis in Rats1

  2006cited by this paper
• IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1

  2005cited by this paper
• Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes.

  2005cited by this paper
• A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

  2005cited by this paper
• Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.

  2005cited by this paper
• Comparison of IL-17 Production by Helper T Cells among Atopic and Nonatopic Asthmatics and Control Subjects

  2005cited by this paper
• Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.

  2005cited by this paper
• T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• IL-6 and the acute phase response in murine atherosclerosis.

  2004cited by this paper
• Inhibition of Tumor Necrosis Factor-&agr; Reduces Atherosclerosis in Apolipoprotein E Knockout Mice

  2004cited by this paper
• Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model: Pharmacotherapeutic Implications

  2004cited by this paper
• Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease.

  2004cited by this paper
• Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators

  2003cited by this paper
• Innate and acquired immunity in atherogenesis

  2002cited by this paper
• IFN-γ Deficiency Exerts Gender-Specific Effects on Atherogenesis in Apolipoprotein E-/- Mice

  2002cited by this paper
• In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice.

  2001cited by this paper
• Reduction of atherosclerosis in mice by inhibition of CD40 signalling

  1998cited by this paper

• JNK Pathway-Associated Phosphatase Deficiency Facilitates Atherosclerotic Progression by Inducing T-Helper 1 and 17 Polarization and Inflammation in an ERK- and NF-κB Pathway-Dependent Manner

  2024cites this paper
• Circulating Interleukin-22 in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2024cites this paper
• The roles of Th cells in myocardial infarction

  2024cites this paper
• Microenvironmental regulation of T-cells in pulmonary hypertension

  2023cites this paper
• Interleukin 17, the double-edged sword in atherosclerosis.

  2022cites this paper
• Polymorphism rs7079 in miR-31/-584 Binding Site in Angiotensinogen Gene Associates with Earlier Onset of Coronary Artery Disease in Central European Population

  2022cites this paper
• Inflammatory Mediators in Atherosclerotic Vascular Remodeling

  2022cites this paper
• The role of interleukin-10 family members in cardiovascular diseases.

  2021cites this paper
• Innate and adaptative immunity: The understudied driving force of heart valve disease.

  2021cites this paper
• Interleukin-22: a potential therapeutic target in atherosclerosis

  2021cites this paper
• Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway

  2021cites this paper
• ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis

  2021cites this paper
• Effects of IL-22 on cardiovascular diseases.

  2020cites this paper
• An overview of the innate and adaptive immune system in atherosclerosis

  2020cites this paper
• Adaptive Immune Responses in Human Atherosclerosis

  2020cites this paper
• Effect of Interleukin-17 in the Activation of Monocyte Subsets in Patients with ST-Segment Elevation Myocardial Infarction

  2020cites this paper
• Tissue Repair Responses and Integrity of the Atherosclerotic Plaque

  2020cites this paper
• T cell subsets and functions in atherosclerosis

  2020cites this paper
• IL‐22 produced by Th22 cells aggravates atherosclerosis development in ApoE−/− mice by enhancing DC‐induced Th17 cell proliferation

  2020cites this paper
• Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome

  2019cites this paper
• Role of interleukin‐17 in acute myocardial infarction

  2019cites this paper
• Dynamic Profile of CD4+ T-Cell-Associated Cytokines/Chemokines following Murine Myocardial Infarction/Reperfusion

  2019cites this paper
• MiR-31 promotes Th22 differentiation through targeting Bach2 in coronary heart disease

  2019cites this paper
• Interleukin-22, a potent target for treatment of non-autoimmune diseases

  2018cites this paper
• Increased expression of interleukin-22 in patients with giant cell arteritis

  2018cites this paper
• Accumulation of T-helper 22 cells, interleukin-22 and myeloid-derived suppressor cells promotes gastric cancer progression in elderly patients

  2018cites this paper
• Interleukin 17A in atherosclerosis - Regulation and pathophysiologic effector function.

  2017cites this paper
• Oxytocin, Tolerance, and the Dark Side of Addiction.

  2017cites this paper
• Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer

  2017cites this paper
• Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications.

  2017cites this paper
• Distinct retrosplenial cortex cell populations and their spike dynamics during ketamine-induced unconscious state

  2017cites this paper
• Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy

  2017cites this paper
• Associations among interleukin-17, interferon-gamma, and acute coronary syndrome

  2017cites this paper
• Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.

  2016cites this paper
• Atherosclerotic Plaque Stability and Vascular Repair

  2016cites this paper
• Characterization of a new sn‐1,3‐regioselective triacylglycerol lipase from Malbranchea cinnamomea

  2016cites this paper
• Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease

  2016cites this paper
• Neuroanatomical correlates of verbal fluency in early Alzheimer's disease and normal aging.

  2016cites this paper
• Metabolic abnormalities in patients with inflammatory rheumatic diseases.

  2016cites this paper
• Inflammation in arterial diseases

  2015cites this paper
• Th22 cells in autoimmunity: a review of current knowledge.

  2015cites this paper
• IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.

  2015cites this paper
• Mechanisms of Improvement of Left Ventricular Function by Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Infusion in Very Old Patients with Coronary Chronic Total Occlusion.

  2015cites this paper
• Regulatory Immune Responses and Repair Mechanisms in Atherosclerosis

  2015cites this paper
• Role of Th1 and Th17 cells in the development and complexity of coronary artery disease: comparison analysis by the methods of flow cytometry and SYNTAX score

  2015cites this paper
• Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis.

  2015cites this paper
• Th 22 cells in autoimmunity : a review of current knowledge

  2015cites this paper
• Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease.

  2015cites this paper
• Th17 Cells in Autoimmune and Infectious Diseases

  2014cites this paper
• Th22 Cell Is a Gradually Proved Potential Biomarker for Acute Coronary Syndrome

  2014cites this paper